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Abstract
The light-gated cation channel Channelrhodopsin-2 (ChR2) is a powerful and versatile tool for controlling neuronal activity.
Currently available versions of ChR2 either distribute uniformly throughout the plasma membrane or are localised
specifically to somatodendritic or synaptic domains. Localising ChR2 instead to the axon initial segment (AIS) could prove an
extremely useful addition to the optogenetic repertoire, targeting the channel directly to the site of action potential
initiation, and limiting depolarisation and associated calcium entry elsewhere in the neuron. Here, we describe a ChR2
construct that we localised specifically to the AIS by adding the ankyrinG-binding loop of voltage-gated sodium channels
(NavII-III) to its intracellular terminus. Expression of ChR2-YFP-NavII-III did not significantly affect the passive or active
electrical properties of cultured rat hippocampal neurons. However, the tiny ChR2 currents and small membrane
depolarisations resulting from AIS targeting meant that optogenetic control of action potential firing with ChR2-YFP-NavII-III
was unsuccessful in baseline conditions. We did succeed in stimulating action potentials with light in some ChR2-YFP-NavII-
III-expressing neurons, but only when blocking KCNQ voltage-gated potassium channels. We discuss possible alternative
approaches to obtaining precise control of neuronal spiking with AIS-targeted optogenetic constructs and propose
potential uses for our ChR2-YFP-NavII-III probe where subthreshold modulation of action potential initiation is desirable.
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Introduction
Gaining precise control over neuronal activity in space and time
is a major goal in experimental and translational neuroscience. In
various model systems, and with increasingly sophisticated
technology, attempts to activate endogenous neural tissue have
employed electrical [e.g. 1,2,3,4,5], magnetic [6] and ultrasound
[7,8] stimulation, with varying degrees of success. Recent years
have also seen major advances in means of controlling neuronal
activity using light [9]. Photocaged compounds such as neuro-
transmitters or divalent ions can be used in combination with focal
photostimulation to mimic fast, local neuronal signals [10], while
synthetically created photoswitch molecules can turn native or
genetically altered proteins, including potassium channels [e.g. 11]
and glutamate receptors [e.g.12], into light-responsive proteins.
Both of these approaches, however, require application of
exogenous compounds to neuronal tissue. An alternative strategy
is to genetically modify neurons so that they produce inherently
light-responsive molecules, an approach known as optogenetics
[13] (although optogenetic proteins do require additional chro-
mophores such as all-trans retinal to become light-sensitive, these
are usually already present in sufficient concentrations in in vitro
neuronal preparations, and in the mammalian brain). The
available range of optogenetic tools is becoming impressively
large. We now have means of hyperpolarising neurons by
activating chloride pumps with yellow light (halorhodopsin, or
(e)NpHR) [14,15,16,17], or by activating proton pumps with
yellow or blue-green light (Arch and Mac, respectively) [18].
There are also increasingly sophisticated ways to depolarise
neurons, including activation of a cation channel with yellow light
(Volvox channelrhodopsin-1, or VChR1) [19], bi-stable excitation
that can be switched on with blue light and off with green light
(step-function opsins or SFOs) [20,21], channelrhodopsin variants
with improved kinetics (e.g. ChEF) [22], and ultra-fast light-
sensitive channels for high-frequency neuronal stimulation
(ChETA) [23]. The most intensely studied, best understood and
most widely used optogenetic tool, however, is channelrhodopsin-2
(ChR2). ChR2 is a cation channel, isolated from the eyespot of
Chlamydomonas algae, which is directly opened by illumination with
a sufficient intensity of blue light (peak excitation ,460 nm) [24].
When expressed in vertebrate neurons, it mobilises efficiently to
the plasma membrane, and upon light stimulation can produce
rapid, large currents carried predominantly by sodium, potassium
and calcium ions [24,25,26]. Activating these conductances under
resting physiological conditions depolarises the neuronal mem-
brane, so if the light stimulus is sufficiently strong, photostimula-
tion combined with ChR2 expression can be used to trigger action
potentials with millisecond resolution [e.g. 25,26]. Amongst a
plethora of current applications, ChR2-induced firing has now
been employed in vitro and in vivo to map neuronal connectivity
[27,28,29,30,31,32,33,34], to induce synaptic plasticity [35,36], to
describe the activity patterns needed for homeostatic plasticity
[37], to demonstrate the formation of functional outputs [38], to
alter behaviour [39,40,41,42,43,44,45,46], and even to restore
function after spinal cord injury [47] or retinal degeneration
[48,49,50, but see 51].
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whether ChR2-driven or not, is a highly-specialised structure
known as the axon initial segment, or AIS. As its name suggests, the
AIS is located near the start of the axon, where it comprises a
complex arrangement of specialised scaffolding proteins, signalling
molecules and ion channels [52,53,54,55]. This dense meshwork of
interconnected proteins provides a barrier for molecular movement
both within the cell membrane [56] and within the cytoplasm [57],
making the AIS crucial in regulating axonal transport, and a key
player in determining the boundary between axonal and somato-
dendritic neuronal compartments [55,58,59,60]. In terms of
electrical activity in the nervous system, however, the AIS plays a
different, vital role. Electrophysiological recordings [e.g. 61,62,63,
64,65,66,67,68,69,70], mathematical modelling approaches [e.g.
68,69,71,72,73] and experiments using voltage [70,74,75] or
sodium [68] indicator dyes all point to the AIS as the subcellular
location where action potentials initiate. This ‘hotspot’ for neuronal
excitability exists by virtue of the AIS’s high concentration of
voltage-gatedsodiumchannels(VGSCs) [68,76], and because of the
low voltage activation threshold of certain VGSC subtypes found
preferentially in its distal region [73,77]. It may also be a surpris-
ingly plastic functional compartment, with recent data showing not
only that the AIS can disassemble rapidly following cellular injury
[60], but also that the structure can relocate along the axon [37], or
change its length [78] in response to long-term changes in electrical
activity.
Basic fluorophore-bound versions of ChR2 distribute indiscrim-
inately throughout the cell membrane, including the AIS [e.g.
26,79]. ChR2 can be targeted to specific neuronal subcompart-
ments, however, by creating fusion protein constructs that bind
preferentially to molecules found in particular cellular regions. For
example, adding the myosin-Va binding domain (MBD) of
melanophilin to the C-terminus of ChR2-YFP produces somato-
dendritic localisation, with ChR2-YFP-MBD largely excluded from
the axon [79]. Fusing the PDZ binding motif ETQV to ChR2-YFP,
on the other hand, targets the ion channel preferentially to the
postsynaptic side of glutamatergic synapses [80]. So far, though,
there are no versions of ChR2 that localise to the AIS, despite the
obvious theoretical benefits of an AIS-targeted optogenetic tool.
Since action potentials initiate at the AIS, being able to control
neuronal depolarisation (or hyperpolarisation) specifically at that
initiation site should allow precise temporal control over firing
behaviour. Action potentials are triggered at the AIS because of its
high concentration of low-threshold voltage-gated sodium channels
[68,73,76], so targeting ChR2 to this most excitable portion of the
cell might also allow for more efficient control over spiking, using
lower light stimulus intensities. Finally, for applications where
accurate spike triggering is the onlygoal, localising ChR2 to the AIS
avoids any complications associated with depolarisation in the soma
and dendrites. This is particularly relevant because ChR2 is
permeable to calcium [24], meaning that strong whole-cell
photostimulation could lead to significant elevations in somatoden-
dritic [Ca
2]i, and subsequently trigger a range of unwanted
intracellular signalling cascades [81].
Localising ChR2 to the AIS might therefore prove extremely
useful. But how could it be achieved? An obvious approach is to
co-opt strategies already used by native AIS-localised proteins. For
example, cell adhesion molecules such as neurofascin (NF)-186
localise to the AIS by binding to the scaffolding protein ankyrin-G,
an interaction which depends upon a C-terminus FIGQY domain
[82,83,84]. Better understood, however, are the AIS-targeting
mechanisms of ion channels, particularly VGSCs. Sodium channel
subunits Nav1.1, 1.2, 1.3 and 1.6 share an ankyrinG binding motif,
critically dependent upon a 9 amino acid sequence, which is
located in the intracellular loop between their second and third
transmembrane domains (II-III loop) [84,85,86,87]. A homolo-
gous motif is also found in KCNQ2/3-type potassium channel
subunits, which, along with VGSCs, bind to ankyrinG and localise
to the AIS [88,89]. The ankyrinG binding domain alone, however,
is not sufficient for AIS targeting of VGSC subunits [87], which
also use a removal sequence in their II-III intracellular loop to
ensure that they are not stably inserted in the membrane elsewhere
in the neuron [87], and several phosphorylation target sites for
protein kinase CK2, also in the II-III loop, to regulate ankyrinG
binding [90,91]. Since all of these necessary components for AIS
targeting are found in the II-III intracellular loop of all Nav1.1,
1.2, 1.3 and 1.6 VGSC subunits [91], it would be no surprise if the
NavII-III loop sequence from any of these subunits were sufficient
to target novel proteins to the AIS. This is indeed the case: fusing
the II-III loop from Nav1.2 to a CD4 extracellular domain [86], or
the extracellular domain of neurofascin [84], GFP [86] or YFP
[37] produces reliable AIS localisation in dissociated hippocampal
cultures.
Here we undertook a similar strategy for ChR2, successfully
localising ChR2-YFP to the AIS by fusing it to the II-III loop
sequence of Nav1.2. This construct was expressed in dissociated
hippocampal neurons without significantly altering their electrical
properties. However, the extremely low magnitude light-evoked
depolarisations resulting from its restriction to the AIS meant that
we were unable to induce light-evoked spikes in cells expressing
ChR2-YFP-NavII-III, except under conditions of artificially
increased neuronal excitability.
Methods
Molecular Biology and Transfections
The ChR2-YFP construct was pLenti-Synapsin-hChR2-
(H134R)-EYFP-WPRE, a gift from Karl Deisseroth (www.
optogenetics.org). We made ChR2-YFP-NavII-III by cloning the






KLWWNLRKTCYKX; MWG) into the BsrgI site found at the
C-terminal end of YFP in the ChR2-YFP plasmid. The appro-
priate base pairs were added to complete the YFP sequence before
the NavII-III sequence began. The construct was verified with
sequencing, and has been submitted for general distribution with
Addgene (www.addgene.org).
Dissociated Hippocampal Cultures
Humane killing for tissue collection conformed to local King’s
College London ethical approval under the UK Supplementary
Code of Practice, The Humane Killing of Animals under Schedule
1 to the Animals (Scientific Procedures) Act 1986. We prepared
dissociated mixed neuronal and glial cultures from E 18 Sprague-
Dawley rat hippocampi according to standard protocols, as
described previously [37]. Briefly, hippocampi were dissected in
HBSS, digested in trypsin (Worthington; 0.5 mg/ml; 15 min
37uC), triturated through Pasteur pipettes of increasingly narrow
diameter, and plated at ,240 cells/mm
2 on glass coverslips pre-
coated with PDL (50 mg/ml) and laminin (40 mg/ml). Cultures
were incubated (37uC, 6% CO2) in a 1:1 mixture of neurobasal
medium plus B27 supplement (2%) and neurobasal medium plus
foetal calf serum (2%), with additional glutamax (500 mM) and
penicillin-streptomycin (100 mg/ml). At 7 days in vitro (DIV) half of
ChR2 at the AIS
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supplement. Cells were transfected at 7 DIV using lipofecta-
mine2000, and were studied between 9 DIV and 12 DIV. Unless
otherwise specified, all culture reagents were from Invitrogen, UK.
Immunocytochemistry
We fixed cells with 1% paraformaldehyde (TAAB Laboratories,
UK; in 3% sucrose, 60 mM PIPES, 25 mM HEPES, 5 mM
EGTA, 1 mM MgCl2; pH 7.4; 20 min RT), washed in PBS, then
blocked and permeabilised in 3% bovine serum albumin (BSA,
Sigma) with 0.4% saponin (Sigma, UK; 1 h RT). We labelled AISs
with a chicken polyclonal anti-bIV-spectrin antibody (a gift from
M. Komada, Tokyo Institute of Technology, Japan; 1:500 in PBS
with 3% BSA, 1 h RT), followed by PBS washes, and then an
Alexa Fluor goat anti-chicken 568 secondary antibody (Invitrogen,
UK; 1:1000; 1 h RT). Coverslips were then given a final PBS
wash, and mounted in Mowiol (Calbiochem, UK).
Imaging and image analysis
Immunostained coverslips were imaged using an Olympus
FluoView 1000 laser scanning confocal microscope coupled to
FluoView software. We used an Olympus 40x oil immersion
objective (0.8 NA). YFP and Alexa Fluor 568 fluorophores were
imaged sequentially using 488 nm and 543 nm lasers, respectively,
along with appropriate excitation and emission filters. Z-axis image
stacks were acquired (102461024 pixels at 2x digital zoom, 0.5 mm
z-axis steps), exported as raw 16-bit TIFF files, converted into single
maximum intensity z-axis projections, and imported into Matlab
(Mathworks, UK) for analysis using a custom-written function [37]
that is freely available at www.grubblab.org/Matlab-scripts.php
and www.mathworks.com/matlabcentral/fileexchange/28181-ais-
quantification. We drew a line profile starting at the soma that
extended down the axon, through and past the AIS. For our first
measure of AIS localisation, we simply took raw fluorescence values
along this line profile for both YFP and bIV-spectrin and calculated
the Spearman correlation coefficient r between the two samples.For
our second measure of AIS localisation, we used measures of the
start and end positions of the AIS, as described previously [37]. At
each pixel (1 pixel =0.155 mm) along the axon line profile, bIV-
spectrin fluorescence intensity values were averaged over a 363
pixel square centred on the pixel of interest. Averaged profiles were
then smoothed using a 40-point (,6 mm) sliding mean, and
normalised between 1 (maximum smoothed fluorescence) and 0
(minimum smoothedfluorescence). AIS startandendpositions were
obtained at the proximal and distal axonal positions, respectively,
where the normalised and smoothed profile declined to 0.33. The
AIS region defined by these start and end positions was then used to
calculate an AIS localisation index (AISi) for the ChR2 constructs
based on normalised, smoothed YFP fluorescence intensities within
and outside the AIS:
AISi~ meanAIS{meannon-AIS ðÞ = meanAISzmeannon-AIS ðÞ
where meanAIS is the mean YFP fluorescence within the AIS
region, and meannon-AIS is the mean YFP fluorescence over all
points outside the AIS region.
Electrophysiology
As previously described [37], we made visually targeted whole-
cell patch-clamp recordings from cultures maintained in a basic
HEPES-buffered saline external solution (pH 7.4, ,280 mOsm,
,23uC) that contained, in mM: 136 NaCl, 2.5 KCl, 10 HEPES,
10 D-glucose, 2 CaCl2, 1.3 MgCl2. Pipettes were pulled from
borosilicate glass (OD 1.5 mm, ID 1.17 mm, Harvard Apparatus,
Edenbridge, UK), with a resistance of 3–7 MV, and were filled
with an internal solution containing, in mM: 130 K-gluconate, 10
NaCl, 1 EGTA, 0.133 CaCl2, 2 MgCl2, 10 HEPES, 3.5 NaATP, 1
NaGTP. Recordings were obtained with a Heka EPC10/2
amplifier coupled to Pulse acquisition software. Signals were
Bessel filtered at 10 kHz (filter 1), and 2.9 kHz (filter 2), digitised,
and sampled at 25–50 kHz (20–40 ms sample interval). Fast
capacitance was compensated in the On-cell configuration.
Electrophysiological parameters were analysed using custom
routines written in Matlab. The resting membrane potential (Vrest)
was estimated immediately following membrane patch rupture in
current clamp mode with zero holding current (I=0) and, like all
voltages in this paper, was adjusted for an estimated liquid
junction potential of ,+15 mV. With slow capacitance compen-
sation inactive in voltage-clamp mode, we used responses to a 10
mV hyperpolarisation step to estimate the neuron’s membrane
resistance (Rm; from the steady holding current at the new voltage)
and membrane capacitance (Cm; from the area under the
exponentially-decaying current from peak to holding).
Voltage-gated sodium currents were measured in basic HBS
external medium (see above) with the addition of 10 mM
tetraethylammonium (TEA; Alfa Aesar, UK) to block voltage-gated
potassium currents, 100 mM CdCl2 (Sigma, UK) to block voltage-
gated calcium currents, 10 mM SR-95531 (gabazine; Sigma, UK) to
block GABAA receptors, 20 mM 6-Cyano-7-nitroquinoxaline-2,3-
dione (CNQX; Sigma, UK) to block AMPA receptors, and 25 mM
DL-2-amino-5-phosphonovaleric acid (APV, Sigma, UK) to block
NMDA receptors. Potassium conductances were additionally
blocked with a Cs-gluconate-based internal solution which
contained, in mM: 130 Cs-gluconate, 10 NaCl, 1 EGTA, 0.133
CaCl2, 2 MgCl2, 10 HEPES, 3.5 NaATP, 1 NaGTP. For these
recordings, series resistance was compensated at $50% (10 ms).
Peak transient sodium currents were measured after subtraction of
scaled passive current responses to the appropriate voltage steps.
Persistent sodiumcurrents wereestimatedfrom the mean whole-cell
current over the final 50 ms of prolonged 500 ms membrane
potential steps. To compensate for passive current contributions the
initial portion of the resulting IV curve was fitted with a regression
line. Subtracting this line from the raw data points then gave an
estimate of persistent sodium current magnitude.
Spiking behaviour in response to 500 ms somatic current
injections was recorded in current-clamp mode with a holding
voltage of 275 mV, using the basic HBS external and K-gluconate-
based internal solutions described above. Spikes were counted as
transient depolarisations passing 0 mV, current threshold (Ithresh)
was measured from the lowest current input that reliably evoked at
least one spike, and voltage threshold (Vthresh) was measured as the
voltage at which the first derivative of the recording (dV/dt)
exceeded 10x the standard deviation of its baseline.
Responses of ChR2-expressing neurons to photostimulation in
on-cell or current-clamp modes were recorded using the basic
HBS external and K-gluconate-based internal solutions described
above, with the addition of 10 mM gabazine, 10 mM CNQX and
25 mM APV to block synaptic conductances extracellularly. In
some recordings, 100 mM Xe 991 and 100 mM linopirdine (Tocris,
UK) were added to the external medium to block KCNQ
channels. Whole-cell ChR2 currents were measured in voltage-
clamp (275 mV) using the Cs-gluconate-based internal solution
and basic HBS external solution supplemented with 10 mM TEA,
1 mM tetrodotoxin (TTX; Alomone Labs, Israel), and 100 mM
CdCl2 to block all main voltage-gated channels, and 10 mM
gabazine, 10 mM CNQX and 25 mM APV to block all main
synaptic conductances. ,488 nm photostimulation at ,170 mW/
ChR2 at the AIS
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2 was provided by a shutter-controlled Xenon-arc lamp
(Lambda-LS, Sutter Instruments, UK) with appropriate excitation
filters (Chroma Tech. Corp., USA) but no neutral density filtering.
More powerful ,1 mW photostimulation was provided by a near-
violet diode 405 nm laser controlled by an Olympus FluoView
1000 confocal microscope.
Statistics
Statistical analysis was carried out in Prism (GraphPad, USA). All
tests were two-tailed, with the level of significance (a) set at 0.05.
Results
We targeted ChR2-YFP to the AIS by adding the Nav1.2
ankyrinG-binding loop NavII-III [84,86] to its intracellular
terminus. When expressed in cultured hippocampal neurons, the
resulting fusion protein ChR2-YFP-NavII-III localised extremely
well to the AIS (Figure 1A, top), unlike ChR2-YFP (Figure 1A,
bottom). We quantifiedthe degree of AIS localisation of these fusion
protein constructs in two ways, both using parallel fluorescent
immunocytochemical staining for the AIS scaffolding protein bIV-
spectrin. In the first, we obtained normalised fluorescence profiles
for bIV-spectrin and YFP along the axon (Figure 1A, right), and
simply calculated the Spearman correlation coefficient r between
these distributions as a measure ofYFP AIS localisation. Meanr was
far higher in neurons expressing ChR2-YFP- NavII-III (mean 6
SEM, 0.5460.04, n=15) than in neurons expressing ChR2-YFP
(0.0960.06, 11; t-test, p,0.0001; Figure 1B). In the second
approach, we used the bIV-spectrin fluorescence distribution to
define the extent of the AIS (see Methods) [37], and obtained an
AIS index (AISi) from the ratio of YFP fluorescence within the AIS
region to YFP fluorescence outside the AIS region (see Methods).
Figure 1. The sodium channel loop NavII-III targets ChR2 to the AIS. A) Example images (left) of neurons expressing ChR2-YFP-NavII-III (top,
note background fluorescence revealing the soma of a non-transfected neuron in the YFP channel, with this cell’s AIS also clear in the bIV-spectrin
channel), or ChR2-YFP (bottom), co-stained for bIV-spectrin. Scalebar, 25 mm. Plots (right) show normalised YFP and bIV-spectrin fluorescence along
the axon, with associated AIS localisation indices. Grey box shows AIS location. B, C) Mean correlation r (B) between YFP and bIV-spectrin
fluorescence, and mean AISi (C; see text) showing AIS localisation of ChR2-YFP-NavII-III. Numbers in bars show n for each group; error bars show SEM;
p values report results of t-tests.
doi:10.1371/journal.pone.0013761.g001
ChR2 at the AIS
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expressing neurons (mean 6 SEM, 0.5660.04; n=15 cells) versus
cells expressing ChR2-YFP (0.0660.09, 11; t-test with Welch’s
correction for unequal variances, p=0.0002; Figure 1C). Addition
of the ankyrinG-bindingloop NavII-III thereforesuccessfully targets
ChR2-YFP to the AIS.
We used whole-cell patch-clamp recordings to verify that
expressing AIS-targeted ChR2-YFP-NavII-III in neurons did not
affect their fundamental electrophysiological properties. Basic
functional parameters including the resting membrane potential
(Vm), whole-cell capacitance (Cm), and passive membrane
resistance (Rm) were not significantly different between neurons
expressing ChR2-YFP-NavII-III (Vm: mean 6 SEM, 261.862.6
mV; Cm: 44.268.5 pF; Rm: 403674 MV; n=8), those expressing
ChR2-YFP (Vm: 261.261.8 mV; Cm: 39.466.1 pF; Rm: 478667
MV; n=9), and non-transfected wild-type (wt) cells (Vm:
257.962.2 mV; Cm: 43.463.9 pF; Rm: 354630 MV; n=11;
Figure 2A–C; one-way ANOVA, F2,27,1.3, p.0.29).
Because ChR2-YFP-NavII-III uses the same mechanism as
native voltage-gated sodium channels to localise to the AIS, we
were concerned that ChR2-YFP-NavII-III expression might result
in competition for ankyrinG binding sites and a consequent
reduction in sodium current magnitude [86]. However, although
there was a trend for ChR2-YFP-NavII-III-expressing neurons to
have lower voltage-gated transient sodium current densities than wt
cells, they displayed a trend towards larger transient sodium current
densities than ChR2-YFP-expressing neurons, and neither of these
trends was statistically significant (Figure 3A,B; repeated-measures
2-way ANOVA: effect of construct, F2,462=1.39, p=0.27; effect of
voltage, F22,462=66.75, p,0.0001; effect of interaction,
F44,462=0.94, p=0.58. Note that a small but significant difference
inseriesresistance(Rs) wasalsoobserved intheserecordings; ChR2-
YFP-NavII-III mean 6 SEM, 10.760.8 MV, n=8; wt, 14.261.2
MV,n=8;Dunn post-testfollowingKruskal-Wallisnon-parametric
one-way ANOVA, p,0.05). Because whole-cell transient sodium
current measurements are particularly sensitive to space-clamp
errors, we also assessed persistent sodium current (INaP) magnitude
in cells expressing ChR2-YFP-NavII-III. This current can be
clamped well in dendritic cells, and is known to emanate from the
AIS [76,92]. We estimated INaP in conditions of synaptic, calcium
and potassium channel blockade by measuring whole-cell currents
observed at the end of prolonged 500 ms voltage steps, after
subtraction of passive current contributions (see Methods;
Figure 3C). The resulting INaP current was entirely blocked by
5 mM TTX (n=3 wild-type neurons,data notshown). We found no
significant differences in INaP magnitude between ChR2-YFP-
NavII-III-positive, ChR2-YFP-positive, and wild-type neurons
(Figure 3D,E; repeated-measures 2-way ANOVA on INaP current
density: effect of construct, F2,361=0.52, p=0.60; effect of voltage,
F19,361=26.95, p,0.0001; effect of interaction, F38,361=1.05,
p=0.40. One-way ANOVA on maximum INaP current density,
F2,21=0.22, p=0.81).
Theseresults weremirrored inmeasuresofactionpotentialfiring.
Cells transfected with ChR2-YFP-NavII-III could fire spikes in
current-clamp mode perfectly well (Figure 4A), and although they
showed trends towards depolarised voltage thresholds (Figure 4B;
ChR2-YFP-NavII-IIImean6SEM,233.862.4mV,n=8;ChR2-
YFP, 238.062.5 mV, n=8; wt, 240.561.3 mV, n=11; one-way
ANOVA, F2,26=2.96, p=0.07), higher current thresholds
(Figure 4C; ChR2-YFP-NavII-III mean 6 SEM, 2.4460.31 pA/
pF, n=8; ChR2-YFP, 2.1560.58 pA/pF, n=8; wt, 1.8460.31
pA/pF, n=11; Kruskal-Wallis non-parametric one-way ANOVA,
p=0.38), and lower maximum spike number (across all current
injection magnitudes for a given cell; Figure 4D; ChR2-YFP-NavII-
III mean 6 SEM, 8.7561.41, n=8; ChR2-YFP, 8.0061.98, n=8;
wt, 12.2762.08, n=11; one-way ANOVA, F2,26=1.51, p=0.24),
none of these trends was statistically significant.
ChR2-YFP-NavII-III therefore localises to the AIS without
affecting the basic health or action potential-generating properties
of its host cells. But can the construct be used to provide
optogenetic control over spiking behaviour? We initially attempted
to evoke action potentials in ChR2-YFP-NavII-III-expressing cells
using blue light from a Xenon arc fluorescent lamp at maximum
intensity (,170 mW/mm
2). This light source is routinely used to
evoke spikes in ChR2-YFP-positive cells in our laboratory, but
even long, 500 ms flashes never produced an action potential in
ChR2-YFP-NavII-III-expressing cells (Figure 5A; on-cell and
current-clamp I=0 recording configurations, n=5). As shown
above, this was not because ChR2-YFP-NavII-III-positive neurons
were unable to fire action potentials per se (Figure 5A, grey trace).
Instead, the problem was one of ChR2 response magnitude, with
the maximum depolarisation produced by light stimulation
measured at the soma (mean 6 SEM, 6.7260.99 mV) being
,20 mV smaller than the depolarisation needed to reach spike
threshold from rest (25.363.15 mV; Figure 5B). We tried to
augment light-evoked ChR2-YFP-NavII-III responses by increas-
ing the intensity of our light stimulus, employing focal AIS
stimulation with a near-violet diode 405 nm laser (,1 mW at the
coverslip surface). However, although this strong stimulus reliably
evoked spikes in ChR2-YFP-positive cells, even when directed to
the soma (Figure 5C, left; 6/6 cells), it never evoked an action
potential in neurons expressing ChR2-YFP-NavII-III (Figure 5C,
Figure 2. Passive electrical properties of neurons expressing ChR2-YFP-NavII-III. A–C) Mean resting membrane potential (A), cell
capacitance (B) and membrane resistance (C) do not differ significantly between ChR2-YFP-NavII-III-positive, ChR2-YFP-positive, or wild-type neurons
(1-way ANOVA, p.0.29). Numbers in bars show n for each group; error bars show SEM.
doi:10.1371/journal.pone.0013761.g002
ChR2 at the AIS
PLoS ONE | www.plosone.org 5 October 2010 | Volume 5 | Issue 10 | e13761right; 0/4 cells). The magnitude of light-evoked responses in
ChR2-YFP-NavII-III-positive cells therefore appears limited by
the low total number of ChR2 molecules present in the cell
membrane. This was evidenced by voltage-clamp recordings of
whole-cell ChR2 currents (Figure 5D), which showed that peak
light-evoked responses were ,28 –fold smaller in neurons
expressing ChR2-YFP-NavII-III versus those expressing ChR2-
YFP (Figure 5E; Xenon lamp stimulation at ,170 mW/mm
2;
ChR2-YFP-NavII-III mean 6 SEM, 42.168.4 pA, n=8; ChR2-
YFP, 1188.56235.3 pA, n=8). So, whilst it localises extremely
well to the AIS, the ChR2-YFP-NavII-III construct simply
provides too little light-evoked current to allow optogenetic control
of spiking under baseline conditions.
We did, however, succeed in producing light-evoked action
potentials in some ChR2-YFP-NavII-III-expressing cells under
rather specialised conditions. As well as clustering the voltage-gated
sodium channels that are vital for spike initiation, the AIS also
contains high densities of voltage-gated potassium channels that
Figure 3. Whole-cell sodium currents in cells expressing ChR2-YFP-NavII-III. A) Example whole-cell transient sodium currents in response to
depolarisation steps from 2105 mV in ChR2-YFP-NavII-III-expressing, ChR2-YFP-expressing, and wild-type neurons. B) No significant difference in
mean whole-cell transient sodium current INa density in the three cell types (effect of cell type in 2-way repeated-measures ANOVA, p=0.27). Error
bars show SEM. C) Example IV relationships for whole-cell persistent currents following 500 ms membrane potential steps in the three cell types. The
linear fit used to subtract passive currents is shown in magenta. D) No significant difference in mean whole-cell persistent sodium current INaP density
across the three cell types (effect of cell type in 2-way repeated-measures ANOVA, p=0.60). Error bars show SEM. E) No significant difference in
maximum persistent sodium current INaP density in the three cell types (one-way ANOVA, p=0.58). Error bars show SEM.
doi:10.1371/journal.pone.0013761.g003
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KCNQ potassium channels, which cluster preferentially at the AIS
[88], with the antagonists Xe-991 (100 mM) and linopirdine
(100 mM) produced broad spikes that were initiated at much less
depolarised membrane potentials, making cells significantly more
excitable. In a subset of neurons expressing ChR2-YFP-NavII-III
(on-cell, 10/17 cells=59%; current-clamp I=0, 9/17 cells=53%),
this allowed the production of single action potentials using long-
duration high-intensity blue light stimulation (Figure 5F). The
temporal precision of spike initiation under these conditions was
poor, however: mean time-to-spike following light stimulus onset in
on-cell mode was 70 ms, with a standard deviation of 37 ms across
all ChR2-YFP-NavII-III-expressing cells.
Discussion
We have shown that the sodium channel NavII-III loop
sequence is sufficient to accurately target ChR2 to the AIS in
cultured hippocampal neurons. Expressing this construct does not
significantly alter the basic functional properties of its host
neurons. However, controlling action potential initiation with
ChR2-YFP-NavII-III proved impossible, even with strong AIS-
directed laser photostimulation. ChR2 currents localised to the
AIS were simply too small to take a neuron past spike threshold,
except under artificial conditions of increased excitability.
As predicted by previous success with simple fluorophore
[37,86] and membrane-bound [84,86] molecules, adding the
entire sodium channel II-III loop to the intracellular terminus of
ChR2-YFP was sufficient to target the protein specifically to the
AIS. Attempts at localising ChR2 to the AIS using only the 9 aa
[84] or 27 aa [86] ankyrinG binding domains were less successful
(data not shown), suggesting that ChR2, like VGSCs, requires the
II-III loop membrane removal sequence [87] and/or CK2
phosphorylation sites [90] for complete AIS targeting. These
multiple mechanisms of subcellular localisation, however, make it
unlikely that the number of ChR2-YFP-NavII-III molecules could
be increased at the AIS by simply increasing expression of the
protein with, say, stronger promoters or lentiviral infection [e.g.
16,93]. Although producing more foreign protein is an obvious
approach to the problem of low ChR2 currents and lack of light-
induced spiking, the need for ChR2-YFP-NavII-III to be
constitutively removed from non-AIS locations [87] means that
cells expressing very high levels of the construct would probably
display impaired AIS targeting – they would be simply swamped
with excess ChR2. Even more pertinent is the fact that ChR2-
YFP-NavII-III uses the same mechanisms as native sodium
[84,86,87,90] and potassium [88] channels to localise to the
AIS. We saw no significant decrease in sodium current density in
our ChR2-YFP-NavII-III-expressing neurons, but we did see a
trend towards lower transient INa amplitude (Figure 3), while
Figure 4. Spiking properties of cells expressing ChR2-YFP-NavII-III. A) Example current-clamp traces in response to 500 ms positive somatic
current injection in the ChR2-YFP-NavII-III-expressing, ChR2-YFP-expressing, and wild-type neurons. Values beneath each trace show current injection
magnitude in pA/pF. B–D) Mean voltage threshold (B; 1-way ANOVA, p=0.07), current threshold (C; p=0.38), and maximum spike number (D;
p=0.24) do not differ significantly across the three cell types. Numbers in bars show n for each group; error bars show SEM.
doi:10.1371/journal.pone.0013761.g004
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with strong expression of GFP-NavII-III [86]. Even if hugely-
increased densities of ChR2-YFP-NavII-III could be precisely
localised to the AIS, then, they might out-compete native VGSCs
to such an extent that action potential initiation is impaired and
light-evoked spiking remains impossible.
Are there other means by which ChR2 can be localised to the
AIS, without competing with native VGSCs? Cell adhesion
molecules such as neurofascin-186 bind ankyrinG and become
AIS-targeted via an intracellular FIGQY motif [82,83,84], so in
theory adding this sequence to ChR2-YFP could localise it to the
AIS without interfering with sodium channel binding sites.
However, although the FIGQY motif is necessary for cell adhesion
molecule binding to ankyrinG, it is not known whether it is
sufficient for AIS targeting. Similarly, another AIS scaffolding
molecule bIV-spectrin requires spectrin repeat 15 for ankyrinG
binding and AIS localisation, but a combination of spectrin
repeats 14+15 proved insufficient for full AIS targeting of a myc
construct [94]. Finally, the clustering of Kv1 channels at the AIS is
dependent upon the scaffolding molecule PSD-93 [95], but the
molecular mechanisms governing this interaction are presently
unclear. There are many alternative potential means of targeting
ChR2 to the AIS, therefore, but none currently understood
sufficiently to be able to be put into practice.
Instead, perhaps the answer to controlling spikes with ChR2 at
the AIS lies away from the AIS targeting mechanism, and more
towards ChR2 itself. Simple cell compartment trafficking sequenc-
es added to the ChR2-YFP-NavII-III construct, for example,
might increase the density of ChR2 molecules at the AIS and
improve optogenetic efficiency [e.g. 17], but with all of the caveats
associated with overexpression outlined above. Alternatively,
variants of ChR2 could be utilised that are more sensitive to
light, or have improved single-channel conductance, producing
larger light-evoked currents with unchanged AIS channel
densities. Such variants are a major future target of optogenetic
molecular engineering. In the meantime there are slow-kinetic
ChR2 mutants which, over time, produce hugely increased
integral currents for a given light stimulus [20,21], and which
could prove useful in evoking spikes via AIS-targeted ChR2
expression, so long as low frequency light-evoked firing is the goal.
Finally, rather than attempting full control over spike initiation
with AIS-localised ChR2, maybe the most attainable target is to
influence action potential firing with optogenetic tools localised to
the AIS. Rather than initiating spikes with AIS-based optogenetics,
action potentials could be specifically inhibited or shaped by light-
driven chloride [14,15,16,17] or proton [18] pumps fused to the
NavII-III sequence. In its native state, the AIS contains multiple
mechanisms for altering the initiation and subsequent properties of
action potentials [53], including voltage-gated potassium channels
[e.g. 96,97], voltage-gated calcium channels [98,99], sodium
channel modulators [100,101] and synaptic inputs [102,103,
104,105]. Returning to the construct described here, perhaps the
Figure 5. Attempting to control neuronal activity with ChR2-YFP-NavII-III. A) Example on-cell (top) and current-clamp I=0 (bottom)
recordings in control HBS solution, showing lack of spiking in a ChR2-YFP-NavII-III-expressing neuron in response to 500 ms blue light stimulation.
Grey trace shows spiking in the same cell in response to somatic current injection. B) Mean depolarisation produced by light stimulation in ChR2-YFP-
NavII-III-positive cells (current-clamp I=0) is much smaller than the mean depolarisation required to fire an action potential from rest. Numbers in bars
show n for each group; asterisks show t-test result; ***, p,0.001. Error bars show SEM. C) ChR2-YFP-NavII-III-positive cells fail to fire even to high
intensity laser photostimulation. Left, brief ,1 mW 405 nm laser illumination targeted to the soma of ChR2-positive cells always produced an action
potential. Right, the same stimulus at the AIS of ChR2-YFP-NavII-III-positive cells never produced an action potential, even though these cells were
capable of firing spontaneous spikes. D) Example whole-cell ChR2 currents in a ChR2-YFP-NavII-III-positive neuron (left) and scaled in comparison to a
typical ChR2-YFP-expressing cell (right), recorded at 275 mV in response to 500 ms blue light stimulation. E) Mean peak whole-cell ChR2 current is
significantly smaller in ChR2-YFP-NavII-III-positive neurons. Numbers in bars show n for each group; asterisks show t-test result; ***, p,0.001. F)
Blocking K
+ channels at the AIS can allow optogenetic control of neuronal activity with ChR2-YFP-NavII-III. Example on-cell (top) and current-clamp
I=0 (bottom) traces in HBS supplemented with 100 mM Xe-991 (xe) and 100 mM linopirdine (lino), showing broad spikes in a ChR2-YFP-NavII-III-
expressing neuron in response to 500 ms blue light stimulation.
doi:10.1371/journal.pone.0013761.g005
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used in various experimental settings to mimic, trigger, or
influence these mechanisms of action potential modulation.
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